INTRODUCTION
The breast cancer resistance protein (BCRP/ABCP/MXR/ABCG2) is a member of the plasma membrane transporter family and is an ATP-binding cassette protein. BCRP was first identified in multidrug-resistant breast cancer cell lines that were selected in the presence of doxorubicin (DOX) and verapamil (Doyle et al., 1998) . BCRP has also been identified in the human placenta (Allikmets et al., 1998) , as well as in cancer cell lines selected in the presence of anti-cancer agents, such as mitoxantrone (Miyake et al., 1999) .
The BCRP gene is located on chromosomal region 4q22, consists of 16 exons that span over 66 kb, and encodes a 72-kDa membrane protein that is composed of 655 amino acids (Allikmets et al., 1998; Doyle et al., 1998; BaileyDell et al., 2001 ).
The normal physiological function of BCRP has not been clearly established. High-level expression of ABCG2 has been observed in certain drug-resistant cell lines and tumors, conferring a special multidrug-resistant phenotype on these cancer cells (Miyake et al., 1999; Litman et al., 2001; Volk et al., 2002) . In normal human tissues, the highest expression of BCRP is seen in the placenta (Allikmets et al., 1998) , while BCRP is expressed at lower levels in the brain, prostate, testis, liver, small intestine, colon, ovary, kidney, and heart (Doyle et al., 1998) . This expression profile suggests that BCRP plays a role in protecting the fetus from toxins (Allikmets et al., 1998; Maliepaard et al., 1999) . BCRP is also known to confer resistance to chemotherapeutic agents, such as mitoxantrone, methotrexate, topotecan, SN38, and flavopiridol (Jonker et al., 2000; Robey et al., 2001 ).
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Several BCRP variants have been reported from direct DNA sequencing of the BCRP gene. Among these, some coding variants of BCRP exhibit increased resistance to anticancer drug treatment (Honjo et al., 2001; Mitomo et al., 2003) . It has been recognized that single nucleotide polymorphisms (SNPs) of BCRP cause inter-individual variations in the pharmacokinetics for BCRP substrates (Sparreboom et al., 2004) .
According to the current literature, the most frequent BCRP polymorphisms detected among different ethnic groups are 34G>A, which codes for V12M, and 421C>A, which codes for Q141K (Zamber et al., 2003) .
The BCRP Q141K SNP has been associated with decreased expression of the BCRP protein in that this genotype produces a reduced transporter activity phenotype (Imai et al., 2002; Kondo et al., 2004) . The BCRP V12M SNP has been reported as having similar activity to the wild-type in terms of DHEAS, MTX, and PAH transport (Kondo et al., 2004) , and porphyrin transport (Ai et al., 2006) . However, Mizuari et al. (2004) have shown disrupted membrane localization of the V12M variant, which results in decreased transport activity.
Despite several reports on BCRP polymorphisms among various ethnic groups, there have been no reports on BCRP SNPs in a Korean population. Therefore, we investigated, for the first time, genetic polymorphisms of the BCRP gene in a Korean population, and performed in vitro functional characterization of a novel regulatory SNP and a coding SNP (P269S). The functional capability of the P269S variant to take up [
H]-ES and [
3 H]-MTX has been reported as being comparable to that of the wild-type protein (Kondo et al., 2004) . However, in the present study, BCRP P269S from human blood samples (not from cell lines) was used for the first time. Functional information on P269S is sparse, as compared to the amount of information that has been collected for other coding variants, such as V12M, Q141K, and the null allele Q126Stop. Since proline is known to be a helix breaker, the three-dimensional structure of the BCRP protein may be affected in the P269S variant. Therefore,
we performed a functional study of the P269S variant among the four variants identified in the study (V12M, Q141K, P269S, and Q126Stop). We also compared the allelic frequencies of the BCRP variants in Koreans to those in Chinese and Vietnamese populations, and we discuss possible ethnic differences with respect to BCRP polymorphisms.
This article has not been copyedited and formatted. The final version may differ from this version. Table 2 . V12M and Q141K were found in 23% and 28% of Koreans, respectively. Q126Stop and P269S were found in 1.9% and 0.2% of Koreans, respectively. The frequencies for the ten intronic SNPs ranged from 10 % to 67%. Recently, Kondo et al. (2004) reported the identification of several BCRP variants, which include A149P, R163K, Q166E, P269S, and S441N, in human cell lines. With the exception of the BCRP P269S variant, these variants were not observed in this study.
Linkage Disequilibrium and Haplotype Structure. LD was analyzed using |D′| values across the common SNPs, which were found with allelic frequencies of >5%. All the SNPs used for the LD analysis exhibited HardyWeinberg Equilibrium (HWE). The positions of eleven common BCRP SNPs calculated by HWE and their haplotype profiles are shown (Fig. 1A) . The LD profile of BCRP showed that all of the SNP pairs in the segment of 34G>A-238A>G-7430A>G-8825C>A were in complete LD (|D′| = 1) (Fig. 1 ). In the second segment covering 6 SNPs (38485A>G-40086insA-42288C>T-44072C>T-44997A>G-45235C>T), all of the SNP pairs, with the exception of the 40086insA/42288C>T pair, were to a large extent in LD, with |D′| = 0.9. The BCRP haplotypes for 11 common SNPs with frequencies >5% were analyzed using the SNPAlyze program (Table 3) . Fourteen haplotypes were predicted to have frequencies >1%. The most frequent allele was the wild-type (26%), followed by the Q141K variant. The haplotype analysis suggests that none of the Q141K-containing haplotypes are linked to the V12M variant. To support this strong linkage, the V12M and Q141K variations were assigned to the same haplotype block among two discrete haplotype blocks of the BCRP gene (Fig.   1B ).
Discovery and Functional Characterization of New SNPs in the
BCRP Promoter. Among the five SNPs found in the promoter region of BCRP, three SNPs (-19855C>T, -19605A>G, and -19031C>T) were identified as novel variants. The frequencies of these novel SNPs were <1.6% and they appeared on different chromosomes. To evaluate the effects of these variants on transcriptional modulating activity, the BCRP promoter-conjugated-luciferase reporter assay was performed. No significant differences were observed between each of the SNPs and the wild-type promoter ( Fig. 2A) . BCRP expression has been reported to be up-regulated through HIF-1α binding to a proximal hypoxia response element (HRE) at the -114 position (Krishnamurthy 19031C>T were introduced into HEK293F cells and treated with deferoxamine, a hypoxia-mimetic agent. In the untreated condition, the variant and wild-type promoters showed similar transcriptional activities (Fig. 2B ). In the presence of deferoxamine, and with co-transfection of the Hif-1α-expressing plasmid, the transcriptional activities of the variant and wild-type were increased to similar extents. These results suggest that this novel SNP in the HRE core site does not cause any alteration of Hif-1α-mediated transcription. The location of -114C>T relative to HRE core region is indicated in Fig. 2C . 3A and 3B ). The expression levels of the wild-type and P269S BCRP proteins were similar, as confirmed by immunoblotting (Fig. 3C) . In order to investigate whether the decreased functionality of BCRP P269S was derived from the modulation of substrate-dependent ATPase activity, prazosine-induced ATPase activity was measured in the wild-type and P269S-expressing microsomes from (Fig.   4 ).
Nonsynonymous Variants of the BCRP Gene in other Asian
Populations. From the screening of four nonsynonymous variants in other ethnic groups, the allelic frequencies of V12M, Q126Stop, Q141K, and P269S
were obtained (Table 4 ). The frequency of V12M was 10-13% higher in Chinese and Vietnamese subjects than in Koreans, whereas Q141K showed no significant differences among the three Asian ethnic groups. The frequency of the Q126Stop variant in Chinese and Vietnamese was <0.5%, although this null variant exhibited a slightly higher incidence (1.9%) in Koreans than in other ethnic groups. The P269S variant was not observed in 100 Caucasians and 100 African-Americans, which suggests that this variant is a rare variant that is found only in Asians.
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Discussion
BCRP was first identified in cell lines that exhibited resistance to mitoxantrone or adriamycin, in which the over-expression of BCRP conferred protection from the cytotoxicities associated with these drugs (Brangi et al., 1999; Maliepaard et al., 1999; Ross et al., 1999) . Many studies of these drugresistant cell lines have indicated that BCRP confers resistance to mitoxantrone, anthracyclines, topotecan, irinotecan, and SN-38 by pumping out the drugs from the cells (Litman et al., 2000; Zhou et al., 2001) .
Recent clinical studies have suggested that the large interindividual variability in drug responses is a consequence of genetic alterations in drug transporter genes. For example, the BCRP Q141K variant has been implicated in the altered pharmacokinetics of diflomotecan (Sparreboom et al., 2004) . This Recently, it has been shown that many genes exhibit a block-like pattern of LD and linkage to each other. The LD pattern observed in the present study shows that there are two discrete blocks of BCRP genes in the Korean population (Fig. 1B) . These two-block structures of LD have also been reported in a Chinese population (Wang et al., 2004) . Most of the SNPs in the individual blocks reveal a high frequency of haplotype structure for the BCRP gene in Koreans (Table 3 ). The wild-type showed the highest frequency at 42%.
Haplotypes 4, 8, and 11 indicate that a single promoter SNP (20296A>G) and the 238A>G change accompany the V12M nonsynonymous change in Koreans (Table 3) . In haplotypes 2, 7, and 13, Q141K (8825C>A) variation is accompanied by 42288C>T and 44997A>G. These strong linkages also demonstrate the block-like haplotype.structure of BCRP gene. For the In the present study, we have described the allele frequencies for BCRP variants in a Korean population and analyzed the function of the P269S coding variant. Kondo et al. (2004) Similarly, BCRP V12M has been reported to exhibit the same transport function as the wild-type (Kondo et al., 2004) , while another study has shown decreased activity caused by disrupted membrane localization (Mizuari et al., 2004) .
Genotyping in clinical studies is needed to address the relationships between these genotypes and phenotypes.
The present study is the first report on the identification of allelic variants of the BCRP gene in a Korean population. In the 92 Korean subjects, twenty SNPs, including four functional variants, were identified in the present study.
We also evaluated the frequency of the four functional variants in two Fig. 3A and B
were immunobloted using anti-BCRP antibody as described in Materials and Method section. 
